The US has warned of the risk of sudden vision loss when using Ozpic, the FDA reports. The disease causes a reduction in blood flow to the optic nerve, but the etiology of the disease has not yet been fully elucidated.
In this regard, the US Food and Drug Administration requires drug manufacturers to include appropriate warnings on the packaging.